Cresset Asset Management, LLC Nuvation Bio Inc. Transaction History
Cresset Asset Management, LLC
- $17.6 Billion
- Q1 2025
A detailed history of Cresset Asset Management, LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 138,816 shares of NUVB stock, worth $324,829. This represents 0.0% of its overall portfolio holdings.
Number of Shares
138,816
Previous 136,435
1.75%
Holding current value
$324,829
Previous $362,000
32.6%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding NUVB
# of Institutions
167Shares Held
156MCall Options Held
4.6KPut Options Held
154K-
Decheng Capital LLC Menlo Park, CA26MShares$60.7 Million12.81% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$38 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.4MShares$36 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA13.1MShares$30.6 Million47.43% of portfolio
-
Laurion Capital Management LP New York, NY9.87MShares$23.1 Million0.45% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $508M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...